chevron_leftBack
As of 20 June 2026, Genomics BioSci & Tech. Co., Ltd. has a market cap of $35.97M USD, ranking #32960 globally and #2014 in Taiwan.
It ranks #2977 in the Healthcare sector, and #574 in the Biotechnology industry.
Key Stats
Market Cap
$35.97MUSD
1.14B TWD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | -3.4% | -18% | -30% | -30% | -30% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4195
基龍米克斯生物科技股份有限公司
ISIN: TW0004195003
Shares Out.:
Shares Outstanding:
72.448M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
15.70 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
15K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
4K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
3K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
2K%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
2K%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
1K%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
507K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
444K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
132K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
123K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
117K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
116K%
33.71B CHF
|
37.2
|
chevron_leftBack